Histogen Inc. (HSTO) Tops Q1 EPS by 59c

Histogen Inc. (NASDAQ: HSTO) reported Q1 EPS of ($0.81), $0.59 better than the analyst estimate of ($1.40). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Histogen Inc. (HSTO) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Ridgepost Capital acquires Stellus Capital Management for $4B AUM